Today: 10 June 2026
Bread Financial (BFH) stock slides on Trump’s 10% credit-card rate cap push; what’s next

Bread Financial (BFH) stock slides on Trump’s 10% credit-card rate cap push; what’s next

New York, Jan 12, 2026, 15:08 EST — Regular session

  • Bread Financial shares dropped roughly 11% amid a selloff in credit-card lenders triggered by news of rate caps.
  • Trump proposed a one-year 10% cap on credit card interest rates beginning Jan. 20, but offered no details on how it would be enforced.
  • Investors are focused on both the legal and political developments, as well as what lenders reveal during earnings calls.

Bread Financial Holdings’ shares dropped 10.8% to $71.65 in afternoon trading Monday, hitting a low of $70.06 earlier in the session.

The move came after President Donald Trump proposed capping credit card interest rates at 10% for one year, beginning Jan. 20. However, Trump didn’t explain how he would enforce compliance among companies.

Why it matters now: Credit cards function as “revolving credit,” letting borrowers carry balances and pay them off gradually. Issuers depend on interest income both to cover defaults and to finance perks. Truist Securities cautioned that the proposal “would swing the business to unprofitable if enacted,” with subprime cards facing the biggest blow. Reuters

The selloff hit consumer-credit stocks hard. Synchrony Financial plunged 8.7%, Capital One tumbled 7.4%, and American Express declined 4.5%.

Some analysts cast doubt on whether the proposal can advance. “It would take an Act of Congress for such rate caps to be in place,” UBS Global noted, warning that an executive order would probably trigger significant legal battles. The same report highlighted the difference between the suggested cap and current card rates — the Federal Reserve’s consumer credit data showed average credit-card interest rates at 20.97% in November. Reuters

For Bread Financial, the stakes are clear. Such a low cap would push issuers to reconsider both their lending targets and pricing — even if they shift costs elsewhere, like fees, limits, or stricter approval standards.

But this political angle might not last. Should Congress stay out of it, Monday’s drop could prove more about risk-off moves and reaction to headlines than a shift in earnings expectations.

Bread Financial announced it will hold its Q4 and full-year 2025 earnings call on Jan. 29 at 8:30 a.m. ET. Investors are expected to focus on credit trends and the company’s take on policy risks tied to card pricing.

The broader market remained uneven. The S&P 500 held steady in late morning trade, while financials slipped around 1%. Investors are gearing up for Tuesday’s U.S. CPI data and the kickoff of major bank earnings, starting with JPMorgan.

Traders are eyeing whether BFH can hold steady into the close and how other card lenders react to any Washington developments. The key date to watch is Jan. 29, when management reports earnings with new figures—and almost certainly faces fresh questions on rate caps.

Stock Market Today

  • Resona Holdings Plans to Boost Individual Shareholders
    June 9, 2026, 11:48 PM EDT. Resona Holdings Inc., a major Japanese banking group, plans to increase its individual shareholder base. As of March, individual shareholders represented just 10.1% of total shareholders, while over 50% were foreign shareholders, primarily institutional investors. This move aims to diversify Resona's investor base and balance its ownership structure amid growing foreign institutional involvement.

Latest articles

Nasdaq Sees More Moves After Hours Following U.S. Strike on Iran

Nasdaq Sees More Moves After Hours Following U.S. Strike on Iran

10 June 2026
U.S. stock futures fell after hours and oil rose as U.S. strikes on Iran fueled risk-off sentiment, deepening losses in tech shares and raising investor caution ahead of Wednesday’s key inflation report, with fears of Fed rate hikes and volatility from the upcoming SpaceX IPO adding pressure.
Keel Slides After $458 Million AI Data-Center Debt Deal Launch

Keel Slides After $458 Million AI Data-Center Debt Deal Launch

10 June 2026
Keel Infrastructure shares plunged 4.24% to $5.42 after closing a $458 million convertible debt sale, reviving investor fears of future dilution even as the company boosts funding for AI-focused data-center projects; shares slipped further to $5.32 after hours on more than double average volume, reflecting concerns over execution risks and the impact of new financing.
Super Micro sinks after $7B AI server plan; dilution a risk

Super Micro sinks after $7B AI server plan; dilution a risk

10 June 2026
Super Micro Computer plans to raise $7 billion through equity and equity-linked financing to fund soaring AI server orders, sending shares down about 9% in after-hours trading as investors focused on dilution risk; the company reported $39 billion in recent AI server orders, but noted these are not firm commitments and cited ongoing legal and regulatory risks.
American Airlines Stock Rises on Google Fuel Deal, Market Watches for Fuel Shock

American Airlines Stock Rises on Google Fuel Deal, Market Watches for Fuel Shock

10 June 2026
American Airlines surged to $14.09, up 48.5 cents, after announcing a three-year sustainable aviation fuel deal with Google covering 35 million gallons, as investors focused on surging fuel costs that jumped 78% in April to $6.5 billion; the stock rose in line with airline peers amid a drop in crude prices, while American’s 2026 outlook remains pressured by higher fuel expenses and a narrowed profit forecast.
Nokia Drops 7% After Nvidia 6G Chatter Hits AI Stocks

Nokia Drops 7% After Nvidia 6G Chatter Hits AI Stocks

10 June 2026
Nokia shares plunged 6.99% to 11.970 euros in Helsinki after reports of Nvidia’s push into future mobile-network tech raised fears over Nokia’s AI-driven growth story, with investors questioning whether Nokia can maintain its edge as competition intensifies and its forward P/E more than doubles this year.
Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape
Previous Story

Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

Summit Therapeutics stock tumbles as FDA filing for ivonescimab hits tape, GSK trial tie-up follows
Next Story

Summit Therapeutics stock tumbles as FDA filing for ivonescimab hits tape, GSK trial tie-up follows

Go toTop